ARCHIVES

Clinical Trials Approved By NCI In November

This article is from The Cancer Letter archive.

Vol. 24 No. 12 | December 28, 2001

Download PDF Visit The Full Archive

Related Articles

FDA cancer therapeutics review split among three units in reorganization.

October 10, 2003

Also Bristol-Myers Squibb Under Federal Investigation Over Plavix Deal.

July 28, 2006

Letters To the Editor: Blumenthal Coverage Called “Destructive”

November 14, 1997

NCI Splits Prevention and control Division; Rimer to Direct Division Of Cancer Conrol

July 25, 1997

DCCP Board Okays New Projects In Chemoprevention, Other Programs Totaling $5 Million In First Year

December 14, 1979

John Ultmann, Chicago’s Outspoken Director, Heads In Retirement

August 30, 1991